Trial intelligence / Profile preview

Oral Ketorolac for Pain Relief During IUD Insertion

NCT03031795Phase 4Completed

Sponsor
OhioHealth
Start
Jul 2014
Primary completion
Mar 2016
Modality
Small Molecules
01

Overview

Phase 4, randomised, double-blind trial of ketorolac, sponsored by OhioHealth. Primary endpoint: Pain Before, During and After IUD Placement. Started Jul 2014; status: completed.

02

Drugs

ketorolac

Beyond the preview

Go deeper on NCT03031795.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03031795.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call